跳至主要内容
临床试验/NCT00690027
NCT00690027已完成不适用

San Diego Bleeding Esophageal Varices Study

University of California, San Diego2 个研究点 分布在 1 个国家目标入组 211 人开始时间: 2008年6月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
211
试验地点
2
主要终点
Survival

研究概览

简要总结

In unselected cirrhotic patients with bleeding esophageal varices to compare the influence on mortality rate, duration of life, quality of life, and economic costs of treatment of:

  • Emergency portacaval shunt, and
  • Emergency and long-term endoscopic sclerotherapy.

详细描述

See attached Synopsis - APPENDIX 1

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

性别
All
接受健康志愿者

入选标准

  • All patients with UGI bleeding (blood in the esophagus, stomach, or duodenum) who enter the emergency room or develop bleeding while in the hospital or are transferred from nearby hospitals and are suspected of having cirrhosis and BEV will be eligible for consideration (all comers).
  • Those who are shown to have the findings of cirrhosis and esophageal varices that:
  • Are seen to be actively bleeding;
  • Have an adherent clot;
  • Have no other associated lesion that could reasonably account for bleeding of that magnitude (such as large gastric or duodenal varices, GU, DU, etc)
  • Require 2 or more units of blood transfusion, will be included in the study.

排除标准

  • 未提供

结局指标

主要结局

Survival

时间窗: 10 years

次要结局

  • Control of bleeding and quality of life(10 years)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

San Diego Bleeding Esophageal Varices Study | 临床试验